|
HS Code |
485453 |
| Generic Name | Oxycodone Hydrochloride |
| Brand Names | OxyContin, Roxicodone, Xtampza ER |
| Drug Class | Opioid analgesic |
| Dosage Forms | Tablets, capsules, solution |
| Route Of Administration | Oral |
| Strengths | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg |
| Controlled Substance Schedule | Schedule II (C-II) |
| Indications | Moderate to severe pain |
| Half Life | Approximately 3 to 5 hours |
| Mechanism Of Action | Binds to mu-opioid receptors in the central nervous system |
| Metabolism | Primarily hepatic, via CYP3A4 and CYP2D6 |
| Common Side Effects | Constipation, nausea, drowsiness, dizziness |
| Manufacturer Examples | Mallinckrodt, Purdue Pharma, Pfizer |
| Pregnancy Category | Category C (US FDA) |
As an accredited Oxycodone Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tamper-evident plastic bottle labeled "Oxycodone Hydrochloride 5 mg," contains 100 tablets, includes dosage instructions and warning labels. |
| Shipping | Oxycodone Hydrochloride is shipped in secure, tamper-evident packaging compliant with all regulatory requirements. Transport is conducted via licensed carriers with chain-of-custody documentation. The chemical is stored at controlled room temperature, away from light and moisture. All applicable DEA, state, and hazardous materials regulations are strictly followed during shipping. |
| Storage | Oxycodone Hydrochloride should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It must be kept in a tightly closed container, protected from light, moisture, and excessive heat. Store securely, away from unauthorized access, as it is a controlled substance. Avoid freezing, and follow all legal and regulatory storage requirements for opioids. |
|
Purity 99%: Oxycodone Hydrochloride Purity 99% is used in oral tablet formulations, where it ensures consistent analgesic potency and minimized impurity risks. Stability Temperature 25°C: Oxycodone Hydrochloride Stability Temperature 25°C is used in pharmaceutical compounding, where it maintains chemical integrity during storage and distribution. Particle Size 50 microns: Oxycodone Hydrochloride Particle Size 50 microns is used in capsule manufacturing, where it promotes uniform blending and precise dosing. Melting Point 220°C: Oxycodone Hydrochloride Melting Point 220°C is used in controlled-release dosage forms, where it allows for stability during processing and predictable release kinetics. Water Solubility 100 mg/mL: Oxycodone Hydrochloride Water Solubility 100 mg/mL is used in injectable solutions, where it enables rapid drug dissolution and enhanced bioavailability. Molecular Weight 351.8 g/mol: Oxycodone Hydrochloride Molecular Weight 351.8 g/mol is used in pharmacokinetic modeling, where it facilitates accurate dose calculations and therapeutic monitoring. USP Grade: Oxycodone Hydrochloride USP Grade is used in clinical trial supply manufacturing, where it guarantees compliance with regulatory quality standards. Assay 98.5-101.5%: Oxycodone Hydrochloride Assay 98.5-101.5% is used in bulk drug production, where it assures batch-to-batch reproducibility and therapeutic efficacy. |
Competitive Oxycodone Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Oxycodone Hydrochloride has become a familiar word in many pain management clinics, emergency rooms, and surgical recovery centers. People hear it in conversations about recovery from injuries, cancer care, or after surgeries that bring relentless pain creeping into every hour. Oxycodone isn't just a name; it represents a world that balances pain relief and risk—a space I’ve had to think about, both professionally and personally, as someone who’s watched loved ones battle serious discomfort and seen the fine line between relief and dependency.
This medication belongs to a class called opioid analgesics. It works within the brain to change how the body senses pain, interrupting signals so a person achieves some comfort. Tablets come in immediate-release and extended-release forms—these are the “models” that people usually mean. Immediate-release brings relief fairly quickly, usually within thirty minutes to an hour, with dosages commonly seen in 5 mg, 10 mg, or 15 mg strengths. This version supports people who experience unexpected spikes in pain or need flexibility. Extended-release formulations stretch out their effect, releasing oxycodone over a longer period and letting patients rest easier overnight or get through a chunk of day without having to carry pill bottles everywhere they go.
Hospitals often rely on these two main forms, sometimes alternating them based on what the patient currently needs. Cancer pain, severe osteoarthritis, and injuries from accidents top the list of reasons for prescription. Medical teams don’t treat this drug lightly because, as effective as it is, the potential for misuse grows each year.
The pharmacy shelf holds dozens of medications for pain. Some are considered “milder,” such as acetaminophen or ibuprofen, which target headaches and minor surgeries but give little help with the torture of a shattered bone or a tumor pressing into nerves. Compared to codeine, oxycodone provides substantially stronger relief—there’s a reason doctors avoid prescribing it for a sprained wrist or toothache.
People sometimes ask how oxycodone differs from similar names like hydrocodone or morphine. On a practical level, oxycodone usually shows a higher absorption rate in the digestive system. Patients often feel its effects a bit more strongly, sometimes with less of the cloudy mind sensation that morphine can bring. Oxycodone hydrochloride tends to deliver steadier pain control at equivalent dosages, making it a preferred choice during post-surgical recoveries when consistency matters.
Anyone who’s kept up with health news or simply watched what happens in their own family knows how polarizing pain medications can be. Oxycodone’s effectiveness for acute pain can’t really be denied. I remember a friend whose parent underwent surgery for a broken hip. Without strong medication, she would have been unable to turn or sleep. Standard painkillers were not enough. The transformation was obvious—she could move a little, try standing, and do essential therapy.
Still, with so much attention on opioid addiction, everybody worries about what repeated use brings. The Centers for Disease Control and Prevention notes that prescription opioids like oxycodone contribute to dependencies that carve new patterns throughout communities. Watching a medication serve as both a vehicle for healing and an entry point to addiction is hard for families and providers alike.
Doctors prescribing oxycodone hydrochloride have to make tough calls. Guidelines demand detailed screening. Providers ask about prior addiction issues, mental health, and history of chronic pain. Doses start low and move up if needed, and medical staff encourage patients to stick to the prescribed instructions, often underlining this with stories about what can go wrong if the medication is shared or saved for later use.
Hospitals and pharmacies have begun tracking prescriptions with state-run databases, looking for duplicated refills or excessive dosages. These tools make it easier to spot risky habits or “doctor-shopping,” but they aren’t foolproof. Even with these layers, busy clinics sometimes miss the subtle signs that a pain plan is veering off track.
Tolerance is familiar territory for anyone who has dealt with chronic pain and long-term medication use. Over time, the body changes the way it responds to oxycodone. You might find a dose helpful at first, but after weeks or months, it loses its potency and pain creeps back. Physicians wrestle with whether to increase the dose or change tactics and add another kind of pain management—sometimes both. They face pressure to do everything possible to keep a patient comfortable, even as they worry the next step could cause harm.
Shifting off oxycodone hydrochloride often proves much harder than starting it. Anyone who’s watched someone taper down an opioid knows the symptoms—muscle aches, watery eyes, agitation, and a restless, miserable energy. For some, nausea sets in, sleep turns impossible, and the urge for one more dose is overwhelming. These challenges make it difficult to step away even once pain improves. This isn’t just about a theoretical “risk.” Studies from major public health agencies confirm that a significant portion of those prescribed opioids for weeks—even for legitimate medical reasons—develop symptoms of physical dependency.
Doctors work closely with patients to plan a slow, controlled taper if the medication is no longer necessary. The goal is to reduce both discomfort and risk of ongoing dependency. Open conversations prove essential. No lecture or warning sheet can replace empathetic, judgment-free support when people are scared about stopping.
Behind statistics and news headlines are daily routines, families, and communities juggling the reality of pain treatment. The stigma around opioids means that patients sometimes delay seeking help, even when they need relief. I’ve seen elderly people refuse pain medication after surgery, worried about what their children might think, or afraid of addiction headlines.
In rural areas where access to care already poses challenges, heavy scrutiny of opioid prescribing creates new barriers. Someone might travel hours to a clinic or struggle to fill a prescription, all while facing judgment. These delays often lead to longer recoveries and higher chances of complications like muscle wasting or depression.
Medical teams increasingly look for ways to either minimize the use of oxycodone or combine its use with other forms of pain relief. This might mean introducing non-opioid medications, physical therapy, acupuncture, or even specialized psychological counseling. Studies published in the Journal of the American Medical Association and elsewhere have shown some combinations lead to less total opioid use and better patient satisfaction. The reality, though, is that many facilities—especially outside large cities—don’t have all these options under one roof.
Insurance coverage becomes another barrier. Extended-release formulations of oxycodone often cost more, even though they can lead to steadier pain control and potentially lower rates of abuse. Non-drug treatments may not be covered at all by some plans, further restricting choices for both doctors and patients.
Oxycodone hydrochloride continues to draw both praise and criticism throughout the medical and public health worlds. It brings powerful benefits, especially for people whose pain is severe enough to break through everyday life and leave them unable to move, eat, or sleep. Most living with this level of pain are grateful for every bit of comfort they can get, even knowing what’s at stake.
Balancing those positives, there’s no end to stories about how quick fixes turn into long-term struggles. A prescription meant to last two weeks sometimes continues for months, then years, especially if there’s not enough support or oversight built into care plans. Friendship circles, workplaces, and extended families often feel the ripple effects. Trust between patients and doctors grows strained as both sides worry about being judged.
The way forward, according to most chronic pain specialists I’ve talked with and research I’ve read, involves more than just tighter controls. Education for patients, families, and prescribers helps clarify the purpose of oxycodone and teach warning signs for dependency or side effects. Tools like lockable pill bottles, follow-up calls by pharmacists, and honest conversations about expectations all go a long way.
Schools sometimes introduce age-appropriate lessons on prescription drugs, not to frighten students, but to give them a vocabulary for talking about pain and medication. Community events or online seminars by local hospitals bring these topics out of the shadows. In my own neighborhood, a single information night led to three people finding safer ways to manage their pain after seeing the warning signs in their own homes.
Pain management remains a moving target. Researchers continue assembling new data on prescribing patterns, efficacy, side effects, and methods for reducing harm. Major studies track outcomes for patients on different regimens, comparing rates of pain relief and opioid use to see where improvements can be made.
One key finding is that personalized plans work better than one-size-fits-all approaches. By tracking factors like age, underlying health, prior use of opioids, and the nature of a patient’s pain, doctors have made real progress in matching pain relief with the minimum dose required. Newer monitoring technologies—software that flags changing prescription patterns or possible “doctor shopping”—give both pharmacies and clinics more tools to catch problems before they spiral out of control.
Decisions regarding oxycodone hydrochloride often spill into family talks, especially when caring for elderly relatives, chronic pain sufferers, or young patients after accidents. Many physicians encourage those close to the patient to join appointments and ask questions. Loved ones often spot personality shifts, memory lapses, or risky behavior before a doctor notices, making their feedback invaluable.
Family discussions also help counter the isolation that often comes with long-term pain or prescription use. Honest, open dialogue—free from blame—brings better outcomes, as patients feel understood and less likely to misuse medications out of frustration or despair.
Recent years have brought new regulations affecting how oxycodone hydrochloride reaches patients. Prescription limits for acute pain—often seven days or less—have become more common across several states. Expanded programs for prescription drug monitoring bring more accountability to physicians and pharmacies, although many say that restricted access alone doesn’t always fix the deeper problems of chronic pain or addiction.
Community support groups and nonprofit organizations play an important part in helping those both starting and ending a course of opioids. Neighbors and volunteers who understand the journey offer advice that resonates: safe storage, proper disposal of unused medication, and steps to protect children from accidental exposure.
It’s clear that oxycodone hydrochloride will remain a central discussion point in health care for a long time. Whether facing cancer treatment, recovering from surgery, or managing a complex injury, people seek relief that allows them to reclaim bits of normal life. Yet neither families nor healthcare providers can ignore the double-edged sword new painkillers deliver.
Medical innovation continues pushing for new, safer therapies—patches, infusions, or genetic testing to fine-tune doses. At the same time, the older lessons of listening, personalizing care, and building community support carry the most staying power.
In clinics and at home, the daily experience teaches a tough lesson: pain is personal and the answer is rarely clear-cut. Oxycodone hydrochloride works best when folded into a larger care plan shaped by each person’s history and goals. Patients who play an active role in their treatment process—tracking symptoms, speaking up when something feels wrong, seeking advice—often find more peace in the journey, even if pain never fully goes away.
Doctors, nurses, family members, and patients are learning together that the goal isn’t just relief, but also safety and dignity. Oxycodone hydrochloride, with its strengths and pitfalls, serves as a reminder: the best care considers not only the science, but also the lived experience of those who count on these medications to get through today and face tomorrow.